4DMEDICAL ORD
Pulmonary imaging takes a leap as UC San Diego Health adopts 4DMedical CT:VQ
4D Medical (ASX: 4DX) inks UC San Diego Health as its 4th US centre to use CT:VQ, with launch pricing ahead of broader commercial rollout.
4DMedical Secures CT:VQ Imaging Commitment Through Expanded Philips Distribution Deal
4DMedical (ASX: 4DX) has secured a minimum US$10 million (A$15m) order commitment for its FDA-approved CT:VQ imaging solution under an expanded distribution agreement with multinational giant Philips.
4DMedical Extends Imaging Technology into Public Hospitals and National Screening Network
4DMedical (ASX: 4DX) has secured three significant agreements to expand the reach of its lung health imaging technology. In Australia, 4DMedical has locked in a multi-year deal with Spectrum Medical Imaging to support the National Lung Cancer Screening Program. The company will also launch a Brazilian lung screening program with a leading pharmaceutical partner, while […]
4DMedical Secures US Medicare Reimbursement Approval for CT:VQ Imaging Software
4DMedical (ASX: 4DX) has received reimbursement approval from the US Centers for Medicare & Medicaid Services (CMS) for its CT:VQ lung imaging platform. The decision follows Food and Drug Administration (FDA) clearance granted last week, aligning regulatory authorisation with a defined payment structure. Together, the approvals clear the path for commercial rollout of the software […]